Lai Chin-Wai, Chung Tak-Shun
Division of Cardiology, Department of Medicine and Geriatrics, United Christian Hospital, Kwun Tong, Hong Kong.
Division of Cardiology, Department of Medicine and Geriatrics, United Christian Hospital, Kwun Tong, Hong Kong.
JACC Case Rep. 2025 May 21;30(11):103315. doi: 10.1016/j.jaccas.2025.103315. Epub 2025 Apr 9.
ABSORB bioresorbable vascular scaffold (BVS) emerged in 2012 aiming to provide early mechanical support while restoring normal vascular function after its complete resorption. Subsequent trials raised safety concerns over early higher scaffold thrombosis rates compared with metallic drug-eluting stent (DES). However, very long-term outcomes of BVS remain insufficiently reported.
A 71-year-old man presenting with stable angina had both BVS and DES implanted in the same vessel in 2014. Restudy angiogram and intravascular optical coherence tomography showed satisfactory outcome of both stents 10 years later.
This case illustrated patient and lesion selection, proper sizing, predilatation, and postdilatation contributed to successful long-term outcome of BVS.
TAKE-HOME MESSAGES: This case demonstrated satisfactory 10-year outcome of BVS that is comparable with DES in the same vessel of the same patient. The patient and lesion selection, proper sizing, predilatation, and postdilatation implantation techniques are the keys to satisfactory long-term outcome of BVS.
ABSORB生物可吸收血管支架（BVS）于2012年问世，旨在在完全吸收后恢复正常血管功能的同时提供早期机械支撑。随后的试验引发了对其早期支架血栓形成率高于金属药物洗脱支架（DES）的安全性担忧。然而，BVS的极长期结果报道仍不充分。
一名71岁男性，因稳定型心绞痛于2014年在同一血管内植入了BVS和DES。10年后复查血管造影和血管内光学相干断层扫描显示两个支架的结果均令人满意。
该病例表明，患者和病变的选择、合适的尺寸、预扩张和后扩张有助于BVS获得成功的长期结果。
该病例显示BVS在同一患者的同一血管中10年的结果令人满意，与DES相当。患者和病变的选择、合适的尺寸、预扩张和后扩张植入技术是BVS获得满意长期结果的关键。
